The authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.
See JNCCN.org for supplemental online content.
Wickerham DL, O'Connell MJ, Constantino JP et al.. The half century of clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). Semin Oncol 2008;35:522–529.
Gradishar WJ, Anderson BO, Balassanian R et al.. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 3.2017. Accessed November 1, 2017. To view the most recent version of these guidelines, visit NCCN.org.
Popescu I, Schrag D, Ang A, Wong M. Racial/Ethnic and socioeconomic differences in colorectal and breast cancer treatment quality: the role of physician-level variations in care. Med Care 2016;54:780–788.
LeMasters TJ, Madhavan SS, Sambamoorthi U, Vyas AM. Disparities in the initial local treatment of older women with early-stage breast cancer: a population-based study. J Womens Health (Larchmt) 2017;26:735–744.
Camacho FT, Tan X, Alcalá HE et al.. Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in Medicare breast cancer survivors. Medicine (Baltimore) 2017;96:e7147.
Lautner M, Lin H, Shen Y et al.. Disparities in the use of breast-conserving therapy among patients with early-stage breast cancer. JAMA Surg 2015;150:778–786.
Wittayanukorn S, Qian J, Westrick SC et al.. Treatment patterns among breast cancer patients in the United States using two national surveys on visits to physicians' offices and hospital outpatient departments. Res Social Adm Pharm 2015;11:708–720.
Inwald EC, Ortmann O, Koller M et al.. Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Res Treat 2017;163:119–130.
Mackey RV, Chandru Kowdley G. Treatment practices and outcomes of elderly women with breast cancer in a community hospital. Am Surg 2014;80:714–719.
Hughes K, Schnaper L, Berry D et al.. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971–977.
Hughes KS, Schnaper LA, Bellon JR et al.. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 2013;31:2382–2387.
VanderWalde N, Jagsi R, Dotan E et al.. NCCN Guidelines Insights: older adult oncology, Version 2.2016. J Natl Compr Canc Netw 2016;14:1357–1370.
Muss HB, Woolf S, Berry D et al.. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005;293:1073–1081.
Muss HB, Berry DA, Cirrincione CT et al.. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 2009;360:2055–2065.
Daugherty EC, Daugherty MR, Bogart JA, Shapiro A. Adjuvant radiation improves survival in older women following breast-conserving surgery for estrogen receptor-negative breast cancer. Clin Breast Cancer 2016;16:500–506.e2.
Reeder-Hayes K, Peacock Hinton S, Meng K et al.. Disparities in use of human epidermal growth hormone receptor 2-targeted therapy for early-stage breast cancer. J Clin Oncol 2016;10;34:2003–2009.
Schonberg M, Marcantonio E, Li D et al.. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol 2010;28:2038–2045.
Luu C, Goldstein L, Goldner B et al.. Trends in radiotherapy after breast-conserving surgery in elderly patients with early-stage breast cancer. Ann Surg Oncol 2013;20:3266–3273.
Tuttle TM, Jarosek S, Habermann EB et al.. Omission of radiation therapy after breast-conserving surgery in the United States. A population-based analysis of clinicopathologic factors. Cancer 2012;118:2004–2013.
Wollschläger D, Meng X, Wöckel A et al.. Comorbidity-dependent adherence to guidelines and survival in breast cancer—is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients. Breast J 2018;24:120–127.
Howlander N, Noone AM, Krapcho M et al., eds. SEER Cancer Statistics Review, 1975-2012, National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975_2011/. Accessed September 22, 2015.
Engels EA, Pfeiffer RM, Ricker W et al.. Use of Surveillance, Epidemiology, and End Results-Medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol 2011;174:860–870.
National Cancer Institute. Division of Cancer Control & Population Sciences. Healthcare Delivery Research Program. SEER-Medicare: About the Data Files. Available at: http://appliedresearch.cancer.gov/seermedicare/aboutdata/. Accessed September 22, 2015.
U.S. Health Resources and Services Administration. Bureau of Health Professions. Area Resource File, 2009-2010 Release. Rockville, MD: U.S. Department of Health and Human Services; Fairfax, VA: Quality Resource Systems, Inc; 2010. Codebook: HE-001.
Carlson RW, Allred DC, Anderson BO et al.. Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2009;7:122–192.
Desch C, McNiff K, Schneider E et al.. American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol 2008;26:3631–3637.
Freedman RA, Virgo KS, He Y et al.. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer 2010;117:180–189.
Working Group on Health Outcomes for Older Persons with Multiple Chronic Conditions. Universal health outcome measures for older persons with multiple chronic conditions. J Am Geriatr Soc 2012;60:2333–2341.
Loggers ET, Buist DS, Gold LS et al.. Advanced imaging and receipt of guideline concordant care in women with early stage breast cancer. Int J Breast Cancer 2016;2016:2182985.
Merrill AY, Brown DR, Klepin HD et al.. Outcomes after mastectomy and lumpectomy in octogenarians and nonagenarians with early-stage breast cancer. Am Surg 2017;83:887–894.
Hurria A, Wong L, Villaluna D et al.. Role of age and health in treatment recommendations for older adults with breast cancer: the perspective of oncologists and primary care providers. J Clin Oncol 2008;26:5386–5392.
Witherby SM, Muss HB. Managing early-stage breast cancer in your older patients. Oncology (Williston Park) 2006;20:1003–1012; discussion 1012–1013, 1017–1018.
Jones EL, Leak A, Muss HB. Adjuvant therapy of breast cancer in women 70 years of age and older: tough decisions, high stakes. Oncology (Williston Park) 2013;26:793–801.
Hamelinck VC, Bastiaannet E, Pieterse AH et al.. A prospective comparison of younger and older patients' preferences for adjuvant chemotherapy and hormonal therapy in early breast cancer. Clin Breast Cancer 2016;16:379–388.
Wallwiener CW, Hartkopf AD, Grabe E et al.. Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated? J Cancer Res Clin Oncol 2016;142:1847–1853.
Klepin HD, Pitcher BN, Ballman KV et al.. Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance). J Oncol Pract 2014;10:e285–292.
de la Morena Barrio P, Conesa MÁ, González-Billalabeitia E et al.. Delayed recovery and increased severity of paclitaxel-induced peripheral neuropathy in patients with diabetes. J Natl Compr Canc Netw 2015;13:417–423.
Gold HT, Makarem N, Nicholson JM, Parekh N. Treatment and outcomes in diabetic breast cancer patients. Breast Cancer Res Treat 2014;143:551–570.